Switching tenofovir disoproxil fumarate to tenofovir alafenamide in a real life setting: what are the implications? von Schwarze‐Zander, C, Piduhn, H, Boesecke, C, Schlabe, S, Stoffel‐Wagner, B, Wasmuth, JC, Strassburg, CP, Rockstroh, JK

Volltext

Cancer risk in HIV-infected individuals on HAART is largely attributed to oncogenic infections and state of immunocompetence von Vogel, M, Friedrich, O, Lüchters, G, Holleczek, B, Wasmuth, J C, Anadol, E, Schwarze-Zander, C, Nattermann, J, Oldenburg, J, Sauerbruch, T, Rockstroh, J K, Spengler, Ulrich

Volltext

Transmission of human immunodeficiency virus I drug resistance - a case report. What are the clinical implications? von Anadol, E, Kaiser, R, Verheyen, J, Schülter, E, Emmelkamp, J, Schwarze-Zander, C, Kupfer, B, Wasmuth, J C, Rockstroh, J K

Volltext

Liver stiffness regression after successful Hepatitis C treatment is independent of HIV coinfection von Malin, JJ, Boesecke, C, Schwarze‐Zander, C, Wasmuth, JC, Schlabe, S, Trebicka, J, Spengler, U, Llibre, JM, Jou, T, Vasylyev, M, Clotet, B, Rockstroh, JK

Volltext

Treatment outcomes of integrase inhibitors, boosted protease inhibitors and nonnucleoside reverse transcriptase inhibitors in antiretroviral‐naïve persons starting treatment von Mocroft, A, Neesgard, B, Zangerle, R, Rieger, A, Castagna, A, Spagnuolo, V, Antinori, A, Lampe, FC, Youle, M, Vehreschild, JJ, Mussini, C, Borghi, V, Begovac, J, Duvivier, C, Gunthard, HF, Rauch, A, Tiraboschi, J, Chkhartishvili, N, Bolokadze, N, Wit, F, Wasmuth, JC, De Wit, S, Necsoi, C, Pradier, C, Svedhem, V, Stephan, C, Petoumenos, K, Garges, H, Rogatto, F, Peters, L, Ryom, L

Volltext

Pulmonary hypertension in HIV infection: a prospective echocardiographic study von Schwarze‐Zander, C, Pabst, S, Hammerstingl, C, Ohlig, J, Wasmuth, JC, Boesecke, C, Stoffel‐Wagner, B, Carstensen, A, Nickenig, G, Strassburg, CP, Rockstroh, JK, Skowasch, D, Schueler, R

Volltext

Screening colonoscopy in HIV‐infected patients: high rates of mucosal abnormalities in a German HIV‐infected cohort von Kasapovic, A, Boesecke, C, Schwarze‐Zander, C, Anadol, E, Vogel, M, Hippe, V, Schmitz, V, Rockstroh, JK, Wasmuth, JC

Volltext

Strong impact of highly active antiretroviral therapy on survival in patients with human immunodeficiency virus‐associated Hodgkin's disease von Hoffmann, Christian, Chow, Kai Uwe, Wolf, Eva, Faetkenheuer, Gerd, Stellbrink, Hans‐Juergen, Lunzen, Jan, Jaeger, Hans, Stoehr, Albrecht, Plettenberg, Andreas, Wasmuth, Jan‐Christian, Rockstroh, Juergen, Mosthaf, Franz, Horst, Heinz‐August, Brodt, Hans‐Reinhard

Volltext

Pharmacokinetics of the combination raltegravir/atazanavir in HIV‐1‐infected patients von Jansen, A, Colbers, EPH, Ven, AJAM, Richter, C, Rockstroh, JK, Wasmuth, JC, Luin, M, Burger, DM

Volltext

Screening colonoscopy in HIV ‐infected patients: high rates of mucosal abnormalities in a G erman HIV ‐infected cohort von Kasapovic, A, Boesecke, C, Schwarze‐Zander, C, Anadol, E, Vogel, M, Hippe, V, Schmitz, V, Rockstroh, JK, Wasmuth, JC

Volltext

Influence of protease inhibitor therapy on lipoprotein metabolism von Berthold, H. K., Parhofer, K. G., Ritter, M. M., Addo, M., Wasmuth, J. C., Schliefer, K., Spengler, U., Rockstroh, J. K.

Volltext

Roc analysis comparison of three assays for the detection of antibodies against double-stranded DNA in serum for the diagnosis of systemic lupus erythematosus von WASMUTH, Jan-Christian, GRÜN, Barbara, TERJUNG, Birgit, HOMRIGHAUSEN, Angela, SPENGLER, Ulrich

Volltext

Lopinavir/ritonavir plus saquinavir in salvage therapy; pharmacokinetics, tolerability and efficacy von LA PORTE, Charles J. L, WASMUTH, Jan-Christian, SCHNEIDER, Katrin, ROCKSTROH, Jürgen K, BURGER, David M

Volltext

Safety, efficacy and development of resistance under the new protease inhibitor lopinavir/ritonavir: 48-week results von Voigt, E, Wasmuth, J-C, Vogel, M, Mauss, S, Schmutz, G, Kaiser, R, Rockstroh, J-K

Volltext

Distribution of autoantibodies and rheumatological manifestations in HIV-positive patients from the University Clinic of Bonn – a pilot study von Becker, EA, Wasmuth, JC, Voigt, E, Schwarze-Zander, C, Emmelkamp, J, Rockstroh, J

Volltext

Rapid virological response is the best predictor for achieving SVR under peg-IFN/ribavirin hepatitis C therapy in HIV/HCV co-infected patients von Janke, M, Luechters, G, Vogel, M, Voigt, E, Wasmuth, JC, Schwarze-Zander, C, Emmelkamp, J, Fätkenheuer, G, Rockstroh, J

Volltext

Phospholipid Autoantibodies and the Antiphospholipid Antibody Syndrome: Diagnostic Accuracy of 23 Methods Studied by Variation in ROC Curves with Number of Clinical Manifestations von Wasmuth, Jan-Christian, Oliver y Minarro, Desamparados, Homrighausen, Angela, Leifeld, Ludger, Rockstroh, Jurgen K, Sauerbruch, Tilman, Spengler, Ulrich

Volltext

Administration of indinavir and low-dose ritonavir (800/100 mg twice daily) with food reduces nephrotoxic peak plasma levels of indinavir von AARNOUTSE, Rob E, WASMUTH, Jan-Christian, FÄTKENHEUER, Gerd, SCHNEIDER, Katrin, SCHMITZ, Karina, DE BOO, Theo M, REISS, Peter, HEKSTER, Yechiel A, BURGER, David M, ROCKSTROH, Jürgen K

Volltext

Comparison of two reduced-dose regimens of indinavir (600 mg vs 400 mg twice daily) and ritonavir (100 mg twice daily) in healthy volunteers (COREDIR) von WASMUTH, Jan-Christian, LA PORTE, Charles J. L, SCHNEIDER, Katrin, BURGER, David M, ROCKSTROH, Juergen K

Volltext

Efficacy and safety of abacavir plus efavirenz as a salvage regimen in HIV-infected individuals after 48 weeks von WASMUTH, Jan-Christian, HERHAUS, Christina, RÖMER, Katja, SALZBERGER, Bernd, KAISER, Rolf, SCHLIEFER, Kirsten, VOIGT, Esther, ROCKSTROH, Jürgen K

Volltext